Subscribe To

Price Alert Latest News Economic Calendar News

PHAR / Pharming Group N.V. (PHAR) Q2 2023 Earnings Call Transcript

Pharming Group N.V. (NASDAQ:PHAR ) Q2 2023 Earnings Conference Call August 3, 2023 7:30 AM ET Company Participants Sijmen de Vries - Executive Director and Chief Executive Officer Anurag Relan - Chief Medical Officer Stephen Toor - Chief Commercial Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Christian Glennie - Stifel Joseph Pantginis - H.C. Read More

Demo Live Account See Partner Details

Content Topics

Pharming

Group

PHAR

2023

Earnings

Call

Transcript

phar

Stock

Posted: Aug 6 2023, 04:51

Author Name: Seeking Alpha

PHAR News

By Zacks Investment Research
September 22, 2023

Pharming Group N.V. Sponsored ADR (PHAR) Soars 14.7%: Is Further Upside Left in the Stock?

Pharming Group N.V. Sponsored ADR (PHAR) saw its shares surge in the last session with trading volume being higher than average.

By Seeking Alpha
September 9, 2023

Pharming Group: Pipeline Progresses With APDS Phase 3 Initiation

Pharming Group NV is a biotechnology firm known for its unique approach to addressing rare and genetic diseases. The company's financials show growth

By PRNewsWire
August 24, 2023

Pharming Group to participate in September investor conferences

LEIDEN, The Netherlands , Aug. 24, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Phar

By Seeking Alpha
August 6, 2023

Pharming Group N.V. (PHAR) Q2 2023 Earnings Call Transcript

Pharming Group N.V. (NASDAQ:PHAR ) Q2 2023 Earnings Conference Call August 3, 2023 7:30 AM ET Company Participants Sijmen de Vries - Executive Directo

By Seeking Alpha
August 6, 2023

Pharming Group N.V. (PHGUF) Q2 2023 Earnings Call Transcript

Pharming Group N.V. (OTCPK:PHGUF) Q2 2023 Earnings Conference Call August 3, 2023 7:30 AM ET Company Participants Sijmen de Vries - CEO Anurag Relan -

By PRNewsWire
July 13, 2023

Pharming Group to report second quarter and first half 2023 financial results on August 3

LEIDEN, The Netherlands , July 13, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms it will rep

By Proactive Investors
May 31, 2023

Tony's or Wonka? Choc maker issues three ‘golden shares'

Tony's Chocolonely, the chocolate maker, has issued three ‘golden shares' aimed at maintaining the group's sustainability pledge. The new governing

By PRNewsWire
May 25, 2023

Pharming Group to attend the following Investor Conferences in June

LEIDEN, The Netherlands , May 25, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharmi

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.